下一代mRNA疫苗可以产生强大的保护,对抗多药耐药的Enterobacteriaceae
1College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, China.
NPJ vaccines
|December 31, 2025
概括
针对新型抗原的新型mRNA疫苗在对抗多药耐药细菌方面表现有前途. 这些疫苗提供了对Klebsiella pneumoniae和E. coli的保护,并有可能对Enterobacteriaceae感染进行更广泛的交叉保护.
科学领域:
- 微生物学 微生物学
- 疫苗学 疫苗学 疫苗学
- 生物技术是生物技术.
背景情况:
- 抗菌素耐药性 (AMR) 是一个日益增长的全球健康威胁,减少了抗生素的有效性.
- 迫切需要新型疫苗来对抗多药耐药 (MDR) 细菌病原体.
研究的目的:
- 开发下一代mRNA疫苗,编码新型抗原来保护MDR阴性细菌.
- 在临床前模型中评估这些mRNA疫苗的疗效和交叉保护潜力.
主要方法:
- 开发mRNA疫苗,编码酸特异运输蛋白 (PstS) 和DUF3748域含蛋白 (YidR) 的融合蛋白.
- 在体外评估蛋白质表达和分泌.
- 在体内对小鼠的疗效研究挑战了Klebsiella肺炎和输血性大肠杆菌 (EHEC) 的挑战.
- 对其他Enterobacteriaceae物种的交叉保护的评估.
主要成果:
- 新型融合蛋白 (PstS-YidR) 在体外具有高度表达和分泌.
- 在小鼠中,mRNA疫苗对K. pneumoniae和EHEC提供了显著的保护,减少了细菌负载和器官损伤.
- 一种基于K. pneumoniae的mRNA疫苗 (KV3) 证明了对K. pneumoniae,EHEC,Salmonella enterica和Shigella flexneri的交叉保护.
结论:
- 使用新型抗原的下一代mRNA疫苗对MDR Enterobacteriaceae有效.
- PstS-YidR融合蛋白是开发广谱疫苗的有希望的向抗原.
- 这些mRNA疫苗具有与MDR细菌感染作斗争的潜力,具有显著的交叉保护能力.
更多相关视频
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
5.0K
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
1.0K
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
911
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
911
01:30Development of Antibiotic Resistance
1.1K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.1K
01:28Antimicrobial Effectiveness
876
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
876
01:23Antimicrobial Proteins
12.9K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.9K